Epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and ERK1/2 pathway. [electronic resource]
Producer: 20150511Description: 141582 p. digitalISSN:- 2314-6141
- Catechin -- administration & dosage
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Survival -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- MAP Kinase Signaling System -- drug effects
- Matrix Metalloproteinase 2 -- biosynthesis
- Melanoma -- drug therapy
- Phosphorylation
- Uveal Neoplasms -- drug therapy
- Uveal Melanoma
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.